Accessibility Menu
 
NanoSphere Health Sciences logo

NanoSphere Health Sciences

(OTC) NSHSF

Current Price$0.01
Market Cap$102,800
Since IPO (2017)-100%
5 Year-97%
1 Year-82%
1 Month+0%

NanoSphere Health Sciences Financials at a Glance

Market Cap

$102,800

Revenue (TTM)

$0.00

Net Income (TTM)

$285.04K

EPS (TTM)

$0.03

P/E Ratio

0.36

Dividend

$0.00

Beta (Volatility)

2.89 (High)

Price

$0.01

Volume

50

Open

$0.01

Previous Close

$0.01

Daily Range

$0.01 - $0.01

52-Week Range

$0.00 - $0.06

NSHSF News

No articles available.

NSHSF: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About NanoSphere Health Sciences

Industry

Pharmaceuticals

CEO

Toby Lim

Headquarters

Vancouver, BC V6E 3V7, CA

NSHSF Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

0%

Return on Capital

13%

Return on Assets

18%

Earnings Yield

2.78%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$102.80K

Shares Outstanding

10.28M

Volume

50

Short Interest

0.00%

Avg. Volume

8.867

Financials (TTM)

Gross Profit

$0.00

Operating Income

$168.72K

EBITDA

$252.48K

Operating Cash Flow

$35.92K

Capital Expenditure

$0.00

Free Cash Flow

$35.92K

Cash & ST Invst.

$2.02K

Total Debt

$30.71K

NanoSphere Health Sciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$102.80K

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

$9.43K

+77.4%

EBITDA

$8.32K

+79.7%

Quarterly Fundamentals

Name
Q3 2025YOY CHG

Net Cash

$42.98K

-113.4%

Accounts Receivable

$13.73K

+23.9%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$45.48K

+42.3%

Return on Assets

17.56%

N/A

Return on Invested Capital

12.66%

N/A

Free Cash Flow

$66.14K

-39.7%

Operating Cash Flow

$66.14K

-39.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CUBTCurative Biotechnology, Inc.
$0.01+0.00%
THERTheralink Technologies, Inc.
$0.00+0.00%
BVAXFBioVaxys Technology Corp.
$0.06+8.38%
BIXTBioxytran, Inc.
$0.04+8.72%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$175.81+0.02%
CDECoeur Mining
$17.88+0.01%
TSLATesla
$380.94+0.04%
SMCISuper Micro Computer
$21.62+0.05%

Questions About NSHSF

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.